Kala Bio, Inc. (KALA)
0.1901
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
0.192
0.00 (0.00%)
After-Hours: 20:00
Kala Bio Price to Book Value : 0.4065 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.4065 |
| October 22, 2026 | 0.3967 |
| October 21, 2026 | 0.408 |
| October 20, 2026 | 0.4057 |
| October 19, 2026 | 0.4119 |
| October 16, 2026 | 0.4061 |
| October 15, 2026 | 0.411 |
| October 14, 2026 | 0.402 |
| October 13, 2026 | 0.556 |
| October 12, 2026 | 0.5987 |
| October 09, 2026 | 0.6286 |
| October 08, 2026 | 0.6342 |
| October 07, 2026 | 0.7698 |
| October 06, 2026 | 0.7784 |
| October 05, 2026 | 0.7752 |
| October 02, 2026 | 0.8233 |
| October 01, 2026 | 0.8968 |
| September 30, 2026 | 0.918 |
| September 29, 2026 | 1.076 |
| September 28, 2026 | 0.9627 |
| September 25, 2026 | 1.017 |
| September 24, 2026 | 1.198 |
| September 23, 2026 | 1.198 |
| September 22, 2026 | 1.281 |
| September 21, 2026 | 1.198 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.153 |
| September 17, 2026 | 1.207 |
| September 16, 2026 | 1.115 |
| September 15, 2026 | 1.086 |
| September 14, 2026 | 1.156 |
| September 11, 2026 | 1.224 |
| September 10, 2026 | 1.204 |
| September 09, 2026 | 1.190 |
| September 08, 2026 | 1.150 |
| September 04, 2026 | 1.085 |
| September 03, 2026 | 1.200 |
| September 02, 2026 | 1.117 |
| September 01, 2026 | 1.138 |
| August 31, 2026 | 1.438 |
| August 28, 2026 | 1.476 |
| August 27, 2026 | 1.737 |
| August 26, 2026 | 1.745 |
| August 25, 2026 | 1.756 |
| August 24, 2026 | 1.701 |
| August 21, 2026 | 1.754 |
| August 20, 2026 | 1.796 |
| August 19, 2026 | 1.924 |
| August 18, 2026 | 1.922 |
| August 17, 2026 | 1.946 |
| August 14, 2026 | 2.022 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.881 |
Price to Book Value Related Metrics
| Price | 0.1901 |
| Earnings Yield | -38.89K% |
| Market Cap | 3.676M |